“Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”, InaJEMD, vol. 1, no. 2, pp. 96–110, Sep. 2024, Accessed: Aug. 03, 2025. [Online]. Available: https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12